Target intelligence / Profile preview

Systemic Ion Homeostasis and Volume Regulation

Molecular classification
Ion channel, Transporter, Receptor, Enzyme
01

Overview

Systemic ion homeostasis and volume regulation is a complex physiological process essential for maintaining the stability of the internal environment, specifically the concentration of electrolytes and the volume of extracellular fluid (StatPearls, 2023). This system involves the integrated function of the kidneys, cardiovascular system, and endocrine glands, utilizing various molecular components such as ion transporters, channels, and receptors (NIH, 2014). It plays a critical role in blood pressure control and the prevention of cellular swelling or shrinkage through osmoregulation (Wikipedia, 2024). Key molecular players include the sodium-potassium-chloride cotransporter (NKCC2), the epithelial sodium channel (ENaC), and the vasopressin V2 receptor. Dysregulation of these mechanisms is a hallmark of several major diseases, including hypertension, congestive heart failure, and chronic kidney disease. Pharmacological agents targeting this system, such as diuretics and inhibitors of the renin-angiotensin-aldosterone system, are among the most widely prescribed medications globally. Because this entry describes a broad physiological process rather than a single molecular entity, it is not classified as a discrete therapeutic target in a molecular sense.

Other names
Fluid and electrolyte balanceOsmoregulationVolume homeostasisWater-electrolyte balance
02

Mechanism of action

Modulation of renal ion transport (e.g., via NKCC2 or NCC inhibition), antagonism of hormonal receptors (e.g., AT1, V2, or Mineralocorticoid receptors), and inhibition of enzymatic pathways (e.g., ACE) to regulate fluid volume and electrolyte concentrations.

03

Biological functions

OsmoregulationBlood pressure regulationElectrolyte balanceAcid-base balanceExtracellular fluid volume maintenance
04

Disease associations

HypertensionCongestive heart failureChronic kidney diseaseEdemaHyponatremiaHyperkalemiaDiabetes insipidusSyndrome of inappropriate antidiuretic hormone secretion (SIADH)
05

Safety considerations

Electrolyte imbalance (e.g., hypokalemia, hyponatremia)DehydrationHypotensionAcute kidney injuryHyperkalemia (associated with RAAS inhibitors)
06

Interacting drugs

Furosemide

7 more in the full profile.

07

Biomarkers

Serum sodium concentrationSerum potassium concentrationPlasma osmolalityUrine osmolalityB-type natriuretic peptide (BNP)Plasma renin activity (PRA)Serum aldosterone levelsFractional excretion of sodium (FeNa)

Beyond the preview

Go deeper on Systemic Ion Homeostasis and Volume Regulation.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Systemic Ion Homeostasis and Volume Regulation.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call